Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

BACKGROUND: Quantification of vertebral bone marrow (VBM) water–fat composition has been proposed as advanced imaging biomarker for osteoporosis. Estrogen deficiency is the primary reason for trabecular bone loss in postmenopausal women. By reducing estrogen levels aromatase inhibitors (AI) as part...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Musculoskelet Disord
Autores principales: Dieckmeyer, Michael, Ruschke, Stefan, Rohrmeier, Alexander, Syväri, Jan, Einspieler, Ingo, Seifert-Klauss, Vanadin, Schmidmayr, Monika, Metz, Stephan, Kirschke, Jan S., Rummeny, Ernst J., Zimmer, Claus, Karampinos, Dimitrios C., Baum, Thomas
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836649/
https://ncbi.nlm.nih.gov/pubmed/31694630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-019-2916-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares